
Peter V. Tishler, M.D.
Corresponding Member of the Faculty of Medicine
Harvard Title
Corresponding Member of the Faculty of Medicine
Administrative and Hospital Titles
Physician to the Active Staff, Division of Genetics, Department of Medicine, Brigham and Women's Hospital
Clinical Affiliate, Department of Medicine, VA Boston Healthcare System
Courtesy Staff, Medicine, Beth Israel Deaconess Medical Center
Consultant Staff, Medical Oncology, Dana-Farber Cancer Institute
Staff, Channing Laboratory, Division of Sleep Medicine
Other Affiliations
Division of Genetics Partners Healthcare System: Partners Center for Personalized Genetic Medicine
Address
Channing Laboratory
181 Longwood Ave
Boston, MA 02115
Publications View
Assessment of genetic and nongenetic influences on pulmonary function. A twin study.
Authors: Redline S, Tishler PV, Lewitter FI, Tager IB, Munoz A, Speizer FE.
Am Rev Respir Dis
View full abstract on Pubmed
Am Rev Respir Dis
View full abstract on Pubmed
Genetic and environmental control of blood pressure in twins and their family members.
Authors: Tishler PV, Lewitter FI, Rosner B, Speizer FE.
Acta Genet Med Gemellol (Roma)
View full abstract on Pubmed
Acta Genet Med Gemellol (Roma)
View full abstract on Pubmed
Sorbent therapy of the porphyrias. V. Adsorption of the porphyrin precursors delta-aminolevulinic acid and porphobilinogen by sorbents in vitro.
High prevalence of intermittent acute porphyria in a psychiatric patient population.
Authors: Tishler PV, Woodward B, O'Connor J, Holbrook DA, Seidman LJ, Hallett M, Knighton DJ.
Am J Psychiatry
View full abstract on Pubmed
Am J Psychiatry
View full abstract on Pubmed
Sorbent therapy of the porphyrias. IV. Adsorption of porphyrins by sorbents in vitro.
Genetic and environmental determinants of level of pulmonary function.
Authors: Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE.
Am J Epidemiol
View full abstract on Pubmed
Am J Epidemiol
View full abstract on Pubmed
Simple screening test for qualitative detection of increased delta-aminolevulinic acid in urine.
Sorbent therapy of the porphyrias. III. Comparative efficacy of experimental plasma perfusion with several commercial hemoperfusion cartridges.
Lung aryl hydrocarbon hydroxylase: inhibition following cadmium chloride inhalation.
Sorbent therapy of the porphyrias. II. Experimental plasma or hemoperfusion with a commercial charcoal cartridge.